Quantum Surgical has developed the Epione® robotic platform, which utilizes image fusion technology to plan and deliver targeted tumor ablation for inoperable abdominal and lung cancers. This technology enables physicians to perform minimally invasive procedures, increasing access to effective cancer treatment for patients with challenging tumor locations.
Funding
$90.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many abdominal and lung tumors are inoperable due to their location, size, or the patient's overall health, limiting treatment options and potentially leading to poorer outcomes. Percutaneous ablation, a minimally invasive alternative, can be challenging due to the difficulty in precisely targeting tumors and confirming successful ablation.
Solution
Quantum Surgical offers the Epione® robotic platform, designed to enhance the precision and efficacy of percutaneous tumor ablation. The system integrates image fusion technology with a robotic arm to assist physicians in planning, targeting, delivering, and confirming tumor ablation. By providing real-time monitoring and precise instrument positioning, Epione® aims to standardize minimally invasive cancer treatment, allowing more patients to benefit from targeted and less invasive procedures. The platform is designed to enable physicians to treat tumors that are difficult to reach, offering a minimally invasive option with the potential for same-day discharge.
Target Audience
The primary target audience includes interventional radiologists and oncologists specializing in percutaneous ablation of abdominal and lung tumors.
Features
- Robotic-assisted technology for planning, targeting, delivering, and confirming tumor ablation
- Image fusion technology to combine CT or MRI images for precise tumor targeting
- Real-time monitoring of patient position during the procedure
- Robotic arm for accurate positioning of ablation instruments
- Minimally invasive approach, potentially reducing hospital stays
- FDA-cleared for CT-guided percutaneous ablation procedures in the abdomen
- Compatible with most FDA-approved ablation devices